milan lab
description
Transcript of milan lab
-
Curing mankind since 1976, Miln Laboratories (India) Private Limited is a
flourishing enterprise dedicated to delivering a product that can take care of
you and your loved ones. We are involved in manufacturing, developing and
exporting pharmaceuticals, which have been produced in strict cGMP
compliant facilities.
We have three dedicated plants, first for manufacture
of Penicillin formulations, second for non-Penicillin
formulations and third for liquid orals, creams and
ointments. While the range of penicillin dosage forms
includes tablets, dry syrups and capsules, the non-
penicillin range covers tablets, capsules, dry syrups,
liquid orals and creams and ointments.
We believe that our cGMP-imbued personnel are our
biggest assets as they perpetually upgrade their knowledge and apply the same
for producing & delivering quality products. Thus, the result of this atude is a
pharmaceucal product produced by professionals through a blend of scienc
acuity and pharmaceucal art.
The fact that we are present in more than 43 countries with over 100 markeng authorizaons and the
several Quality Cercaons, awards and approvals that we have to our credit are the evidence of the same.
Connual improvement is our policy as the company has been adapng to current trends and requirements
while adding newer approvals and opening newer markets for business with each passing day.
The latest cGMP norms are a habit and Quality is our culture.
Upcoming Manufacturing Facility
We are presently expanding and building a new manufacturing facility to cater to the regulated
markets - USA and UK.
This fully integrated state-of-the-art manufacturing plant is situated at Dahej (Guajarat), in an area of
37664 Sq. Mt.
The facility will be dedicated for Oral solid dosage forms.
ABOUT US
info.milanlabs.com 1
-
Milan has made its own contribuon with a wide range of well-known products in various segments. Our wide
range of products encompasses an array of therapeuc segments.
The present product range of Milan is divided into its divisions focusing on various therapeuc segments.
v An-bacterials
v An-infecves
v An-allergics
v Cardiovasculars
v Anthelmencs
v An-malarials
v An- diabecs
v An-inammatory, An-pyrecs, Analgesics
THERAPEUTIC SEGMENTS COVERED
Assurance of quality is provided by the quality systems adopted by Milan. The in-process controls, usage of
qualied machinery, validated manufacturing processes, validated cleaning procedures, strict environmental
monitoring and microbiological controls in all areas, are just a few of the many controls exercised by Milan to
ensure that Quality is built into the product. Furthermore, adequate training of personnel, maintaining
hygiene and cleanliness, proper recording and data handling compliment to our stringent quality policy.
The Quality Control secon is well equipped with professionals operang Sophiscated instruments for
performing analysis of incoming materials, in process and nished products.
The plants are inspected by the Drug Regulatory Authories of various countries and the constant eorts by
the Quality Operaons cell has enabled us to have a very good success rate so far with registraons in several
countries.
QUALITY PRODUCTS
Dosage
Forms
www.milanlabs.com 2
-
Our products are manufactured in facilities that have approvals from stringent regulatory authorities
like....
APPROVALS WE HOLD
South Africa: Medicines Control Council (PIC Country)
Ghana: Foods and Drugs Board
Ethiopia: Drug Administration and Control Authorithy
Democratic Republic of Congo: Ministry of Health
Nigeria: National Agency for Food & Drug Administration & Control
Namibia: Namibia Medicines and Regulatory Council
Malawi: Pharmacy, Medicines and Poison Board
Kenya: Pharmacy & Poisons Board
Sudan: Ministry of Health
Sierra Leone: Pharmacy Board
Republic of Angola: Ministry of Health
Botswana: Ministry of Health
Bhutan: Drug Regulatory Authority
Cte dIvorie : Ministry of Health
Uganda: National Drug Authority
United Kingdom: Medicines and Healthcare products Regulatory Agency
Tanzania: Tanzania Food and Drugs Authority
Zimbabwe: Medicines Control Authority Of Zimbabwe
Ukraine: Ministry of Health
info.milanlabs.com 3
India: WHO cGMP Cered
-
MARKETS WE CATER
As on March, 2015, India Brand Equity Foundaon quotes India as one of the fastest-growing pharmaceucal
markets in the world and that India has established itself as a global manufacturing and research hub. A large raw
material base and the availability of a skilled workforce give the industry a denite compeve advantage.
The Indian pharmaceucal industry was esmated to be worth US$ 12 billion in 2013 and is expected to touch
US$ 100 billion by 2025
Globally, India ranks third in terms of volume of producon and fourteenth largest by value and is also
expected to move up to eleventh place by 2017
Indian pharma sales stood at US$ 22.6 billion in 2012 and is expected to register US$ 27 billion by 2016 growing
at a rate of 14.4 percent
The pharmaceucal exports market in India is growing at a very rapid rate.
India exports to more than 200 countries; its share of exports is expected to grow manifold
Pharmaceucal exports from India grew at a rate of 1.2 per cent to reach US$ 14.84 billion in 2013-14
Looking at this the world is now considering India as the protable venue to manufacture its pharmaceucal
products. Pharma export market in India is very potenal for the buyers for procuring their required
pharmaceucal formulaons in all the available dosage forms.
Milan has achieved remarkable success in exporng pharmaceucal products to over 43 countries spread in all
the connents of the world. We are looking forward to make such e-ups and nd new customers to whom we can
oer our spare capacity and export pharmaceucal formulaons to the markets where we are sll not present.
www.milanlabs.com 4
-
REGULATORY AFFAIRS
Pharmaceucal Industry is a non-stagnant, forever evolving
industry, that demands new formulaons and improved
ecacy. To comply with these needs and to deliver maximum
paent compliance, a dedicated Research and Development
Facility is constantly engaged in developing dierent types of
generic/o-patent formulaons. Apart from working on new
products, the R&D also improvises on the exisng formulaons
at Milan, thus ensuring not only the quality but also beer
products. The R&D is also engaged in analycal method
development and validaon for the drug and drug formulaons
under development.
The Research and Development team comprises of highly
competent professionals including experts with more than 25 years of experience in pharmaceucals who are
passionate about the cra of Formulaons and Development.
RESEARCH AND DEVELOPMENT
Milan also has an independent regulatory aairs team which is dedicated for dossier preparaon and
coordinaon with drug authories of dierent countries. This team comprises of qualied individuals who are,
constantly updang their knowledge and informaon bank to make dossier which is country specic, ecient in
query solving and compleng registraon formalies within melines.
This team is procient in regulatory submissions like -
CTD
ACTD
NeeS
eCTD
Any other country specic format
info.milanlabs.com 5
CTD ACTD
NeeS eCTD
Other
-
www.milanlabs.com 6
YOUR TRUSTED PARTNER FOR ALL QUALITY PHARMACEUTICAL REQUIREMENTS
Research & Development
Markeng Assistance
High Quality
Manufacturing
Complete Technical Support
Regulatory Aairs
-
303-304, Odyssey IT Park, Wagle Estate, Road No. 9, Thane (w) - 400604, Maharashtra, India.
Tel No.: +91-22-25877733/ 34, Fax No: +91-22-25877736
Email: [email protected], Website: www.milanlabs.com
We manufacture only those quality products,
which we can safely give to our
Parents and Children.
Page 1Page 2Page 3Page 4Page 5Page 6Page 7Page 8